The Significance of Sentinel Node Analysis in Colon Cancer

This study has been terminated.
(Slow accrural to study.)
Sponsor:
Information provided by:
Legacy Health System
ClinicalTrials.gov Identifier:
NCT00419978
First received: January 5, 2007
Last updated: June 27, 2008
Last verified: June 2008
  Purpose

This study is for the patient with colon cancer, who is going to have colon cancer surgery. The purpose of this research study is to examine a specific lymph node, called the sentinel node. Lymph nodes are located throughout your body and cancer may spread by means of those lymph nodes. The sentinel node is the one located closest to your tumor. This study will find out if examining the sentinel node can help to predict disease progression. Since the value of this exam is unknown, taking part in this study will not change your clinical care.


Condition Intervention
Colon Cancer
Procedure: Colectomy

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: The Significance of Sentinel Node Analysis in Colon Cancer

Resource links provided by NLM:


Further study details as provided by Legacy Health System:

Enrollment: 24
Study Start Date: June 2004
Study Completion Date: May 2008
  Eligibility

Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All patients must consent to participate in study
  • Patients will be tracked for five years
  • A blood test (CEA) will be collected every six months
  • A CT scan will be performed annually
  • A colonoscopy will be performed at 1 and 5 years post-surgery
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00419978

Locations
United States, Oregon
Legacy Good Samaritan Hospital and Medical Center
Portland, Oregon, United States, 97210
Sponsors and Collaborators
Legacy Health System
Investigators
Principal Investigator: Mark Whiteford, MD Legayc Health System
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00419978     History of Changes
Other Study ID Numbers: 750040399
Study First Received: January 5, 2007
Last Updated: June 27, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Colonic Neoplasms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases

ClinicalTrials.gov processed this record on September 14, 2014